
Mechanisms of development of medicine stability <i>Mycobacterium tuberculosis</i>: is there a chance to win?
Author(s) -
А. Г. Наумов,
А. В. Павлунин
Publication year - 2021
Publication title -
pulʹmonologiâ
Language(s) - English
Resource type - Journals
eISSN - 2541-9617
pISSN - 0869-0189
DOI - 10.18093/0869-0189-2021-31-1-100-108
Subject(s) - tuberculosis , mycobacterium tuberculosis , medicine , adaptability , drug resistance , resistance (ecology) , drug development , intervention (counseling) , intensive care medicine , risk analysis (engineering) , management science , drug , biology , pharmacology , pathology , nursing , engineering , ecology , microbiology and biotechnology
The scientific review provides current information on the current epidemiological status of tuberculosis in our country and the world, genetic adaptability and the evolution of Mycobacterium tuberculosis . The well-known and recently discovered molecular targets of aggression of this microorganism are described, and possible methods of circumventing the resistance of the Office to existing and developed drugs are presented. Objective : to create a scientific analytical review, which allows you to form an idea of the basic principles of development of the mechanisms of drug resistance of M. tuberculosis , as well as ways to overcome them with the possibility of further development of the chosen direction with the involvement of reputable scientific groups and practical implementation. Methods . scientific analysis of international reports, highly indexed scientific articles and clinical protocols. Results . Ihanks to the conducted analytical work, critical biological markers of M. tuberculosis immunity to anti-tuberculosis therapy were identified, which protect it from pharmacological intervention by the person and do not adequately sanitize the centers of inflammation in the patient's body. Methods have been proposed for disintegrating the mechanisms of drug resistance, which will bring the algorithms for treating tuberculosis infection to a new level. Conclusion . The analyzed information will contribute to deepening and expanding the knowledge of specialists involved in the fight against tuberculosis about the importance of implementing a personalized approach in the provision of medical care to TB patients, taking into account the studied molecular indicators of resistance to standardized and developed drugs.